Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cédric Poyet

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
BJU International|October 19, 2016
Prostate cancer risk calculators: still much work aheadCédric Poyet, Thomas Hermanns
European Urology|May 20, 2017
The Next Generation of Prostate Cancer Risk CalculatorsThomas Hermanns, Cédric Poyet
Translational Andrology and Urology|April 9, 2024
Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancerThomas Paul Scherer, Cédric Poyet
European Urology Open Science|October 3, 2025
Reply to Ilias Giannakodimos, Zisis Kratiras, and Michael Chrisofos' Letter to the Editor re: Thomas Paul Scherer, Dominik Menges, Uwe Bieri, et al. Impact of Prebiopsy Multiparametric Magnetic Resonance Imaging on Prostate Cancer Detection in Switzerland. Eur Urol Open Sci 2025;73:1-7Thomas Paul Scherer, Cédric Poyet
Praxis|March 3, 2016
[Male Urinary Incontinence--a Taboo Issue]Marko Kozomara-Hocke, Thomas Hermanns, Cédric Poyet
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Artificial prostate-specific antigen persistence after radical prostatectomyCédric Poyet, Danielle Hof, Tullio Sulser, et al.
Biotechniques|February 5, 2016
IDLN-MSP: Idiolocal normalization of real-time methylation-specific PCR for genetic imbalanced DNA specimensSimeon Santourlidis, Foued Ghanjati, Agnes Beermann, et al.
Anti-Cancer Drugs|March 8, 2006
MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxalAndré Fedier, Cédric Poyet, Daniele Perucchini, et al.
BMC Urology|June 14, 2013
Therapy-resistant nephrolithiasis following renal artery coil embolizationCédric Poyet, Florian Grubhofer, Matthias Zimmermann, et al.
Urology|April 29, 2015
Long-term Adverse Effects of Extracorporeal Shock-wave Lithotripsy for Nephrolithiasis and Ureterolithiasis: A Systematic ReviewChristian D Fankhauser, Benedikt Kranzbühler, Cédric Poyet, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
BJU International|October 19, 2016
Prostate cancer risk calculators: still much work aheadCédric Poyet, Thomas Hermanns
European Urology|May 20, 2017
The Next Generation of Prostate Cancer Risk CalculatorsThomas Hermanns, Cédric Poyet
Translational Andrology and Urology|April 9, 2024
Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancerThomas Paul Scherer, Cédric Poyet
European Urology Open Science|October 3, 2025
Reply to Ilias Giannakodimos, Zisis Kratiras, and Michael Chrisofos' Letter to the Editor re: Thomas Paul Scherer, Dominik Menges, Uwe Bieri, et al. Impact of Prebiopsy Multiparametric Magnetic Resonance Imaging on Prostate Cancer Detection in Switzerland. Eur Urol Open Sci 2025;73:1-7Thomas Paul Scherer, Cédric Poyet
Praxis|March 3, 2016
[Male Urinary Incontinence--a Taboo Issue]Marko Kozomara-Hocke, Thomas Hermanns, Cédric Poyet
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Artificial prostate-specific antigen persistence after radical prostatectomyCédric Poyet, Danielle Hof, Tullio Sulser, et al.
Biotechniques|February 5, 2016
IDLN-MSP: Idiolocal normalization of real-time methylation-specific PCR for genetic imbalanced DNA specimensSimeon Santourlidis, Foued Ghanjati, Agnes Beermann, et al.
Anti-Cancer Drugs|March 8, 2006
MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxalAndré Fedier, Cédric Poyet, Daniele Perucchini, et al.
BMC Urology|June 14, 2013
Therapy-resistant nephrolithiasis following renal artery coil embolizationCédric Poyet, Florian Grubhofer, Matthias Zimmermann, et al.
Urology|April 29, 2015
Long-term Adverse Effects of Extracorporeal Shock-wave Lithotripsy for Nephrolithiasis and Ureterolithiasis: A Systematic ReviewChristian D Fankhauser, Benedikt Kranzbühler, Cédric Poyet, et al.
Pageof 11